Texas 2019 - 86th Regular

Texas House Bill HB2353

Caption

Relating to administrative and other expenditures by Medicaid managed care organizations.

Impact

The introduction of House Bill 2353 is likely to have a significant impact on how Medicaid managed care organizations operate in Texas. By compelling these entities to report their expenditures in detail, the bill aims to provide a clearer picture of how funds are utilized. This measure could potentially lead to more efficient use of Medicaid funds, ensuring that the financial resources are utilized primarily for clinical services and patient support rather than administrative functions. Such transparency could enhance the quality of care provided to enrollees and foster more effective oversight by state agencies.

Summary

House Bill 2353 seeks to regulate the administrative and other expenditures by Medicaid managed care organizations in Texas. The bill introduces provisions that allow the legislature to establish upper limits on the percentage or amount of Medicaid payments that these managed care organizations may allocate towards administrative costs, including overhead and marketing expenses. This regulation is intended to improve transparency and hold these organizations accountable for their financial practices while also ensuring that a significant portion of funding is directed towards patient care and services rather than administrative overhead.

Contention

While the bill is framed as a necessary step towards fiscal responsibility in Medicaid spending, it may also prompt controversy regarding the operational capacity of managed care organizations. Critics may argue that imposing strict limits on administrative spending could hinder these organizations' ability to effectively manage care and deliver quality services. There may be concerns that such measures could lead to unintended consequences, such as reducing the ability of these organizations to invest in essential administrative functions that support care delivery and patient management. As the bill progresses, discussions on its potential ramifications are expected to shape its legislative journey.

Companion Bills

No companion bills found.

Previously Filed As

TX HB4611

Relating to the nonsubstantive revision of the health and human services laws governing the Health and Human Services Commission, Medicaid, and other social services.

TX SB2402

Relating to the creation, management, and administration of the Texas Pharmaceutical Initiative.

TX HB5023

Relating to requiring Medicaid managed care organizations to provide an annual bonus payment to certain Medicaid providers.

TX HB1283

Relating to prescription drug formularies applicable to the Medicaid managed care program.

TX SB1113

Relating to prescription drug formularies applicable to the Medicaid managed care program.

TX SB2244

Relating to certain evidence-based community support services offered by a Medicaid managed care organization in lieu of other services.

TX HB5018

Relating to certain payment recovery efforts by managed care organizations under Medicaid or the child health plan program.

TX HB1701

Relating to administrative and judicial review of certain Medicaid reimbursement disputes; authorizing a fee.

TX HB2307

Relating to the retention by a managed care organization of certain money recovered as a result of a fraud or abuse investigation under Medicaid or the child health plan program.

TX SB935

Relating to the retention by a managed care organization of certain money recovered as a result of a fraud or abuse investigation under Medicaid or the child health plan program.

Similar Bills

No similar bills found.